Secteur Celyad Oncology SA Börse Stuttgart
Actions
1C0
BE0974260896
Recherche biotechnologique et médicale
|
Temps Différé
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
| 0,2270 EUR | +7,58% |
|
+2,43% | +33,97% |
| 14/07 | Celyad Oncology va lever des fonds via un placement privé | MT |
| 15/04 | Prelude Therapeutics Incorporated nomme Charles Morris au poste de Chief Medical Officer, avec effet au 20 avril 2026 | CI |
Principaux concurrents
Ajouter à une liste 0 sélectionné | Varia. | Varia. 5j. | Variation 1 mois | Variation 3 mois | Varia. 1 janv. | Varia. 1an | Varia. 3ans | Varia. 5ans | Varia. 10ans | Capi.($) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0,18% | -3,16% | +12,71% | +10,37% | +4,87% | +0,43% | +14,89% | -14,96% | +215,97% | 48,71 Md | |
| +1,86% | -1,12% | +10,30% | +22,83% | +129,62% | +376,03% | +583,19% | +505,00% | - | 38,35 Md | |
| +1,98% | +3,39% | +16,62% | +1,49% | +4,33% | +8,58% | +60,49% | +3,37% | +1 047,18% | 34,53 Md | |
| -1,48% | -2,96% | +20,18% | +14,79% | -10,53% | +26,87% | -11,64% | -17,01% | +176,69% | 34,03 Md | |
| -0,58% | -2,00% | +0,76% | -12,32% | -0,45% | -0,07% | +31,08% | -23,55% | +140,83% | 26,77 Md | |
| +0,89% | -4,40% | +11,36% | +5,66% | - | - | - | - | - | 15,64 Md | |
| +1,12% | -0,25% | +17,38% | +3,87% | -4,77% | +73,15% | +118,05% | +193,06% | - | 15,08 Md | |
| -2,03% | +0,96% | +9,74% | +0,43% | +11,63% | +13,12% | +14,01% | -30,47% | +103,74% | 14,18 Md | |
| -0,54% | -1,76% | +17,25% | +43,26% | -9,44% | +18,18% | -32,90% | -22,92% | +132,21% | 12,73 Md | |
| -0,51% | -1,01% | +36,95% | +19,90% | -2,41% | +1 204,11% | +612,99% | +270,08% | +2 751,94% | 11,61 Md | |
| -0,08% | +0,49% | +28,72% | +19,96% | +21,71% | +42,39% | -19,95% | -38,18% | +158,20% | 11,16 Md | |
| -0,26% | -5,04% | +20,93% | +19,91% | +10,07% | +46,58% | +6,39% | -43,09% | +155,27% | 10,58 Md | |
| +0,03% | +0,16% | +1,23% | +47,67% | +77,76% | +243,07% | +557,72% | - | - | 10,05 Md | |
| +1,49% | -0,14% | +12,55% | +27,09% | +43,85% | +147,96% | +417,23% | +95,68% | - | 9,14 Md | |
| +1,92% | -15,89% | +3,13% | -10,52% | -16,43% | -14,93% | - | - | - | 8,69 Md | |
| +2,82% | +4,19% | +18,90% | +29,16% | +56,59% | +147,68% | +583,85% | +185,18% | - | 8,64 Md | |
| +0,56% | -3,30% | -30,00% | -28,96% | -32,85% | +27,85% | +30,68% | +44,70% | +91,42% | 8,75 Md | |
| +5,58% | +15,49% | +73,32% | +28,67% | +38,45% | +49,71% | +58,07% | -55,67% | - | 9,21 Md | |
| +1,28% | +1,22% | +13,49% | +55,82% | +86,67% | +95,91% | +63,63% | +116,72% | +6,66% | 8,62 Md | |
| Moyenne | +0,73% | -1,74% | +15,55% | +15,74% | +22,70% | +139,26% | +181,63% | +73,00% | +452,74% | 17,71 Md | |
| Moyenne pondérée par Capi. | +0,52% | -1,62% | +14,59% | +12,94% | +23,76% | +120,29% | +160,03% | +83,90% | +432,36% |
- Bourse
- Actions
- Action CYAD
- Action 1C0
- Secteur Celyad Oncology SA
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
